J. Huang

Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion.

E. Bates, B. Lucchesi, S. Rebello, 1999, European journal of pharmacology.

Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro.

J. Huang, S. Ryan, D. Liau, 1996, Biochimica et biophysica acta.

Pharmacokinetics and pharmacodynamics of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized dogs.

B. Lucchesi, S. Rebello, K. Saito, 1998, Journal of cardiovascular pharmacology.

In vivo efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood.

B. Lucchesi, S. Rebello, K. Saito, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Down but not out: new insights into the role of alphaVbeta3 integrins in vascular healing.

G. Stouffer, A. Pathak, R. Zhao, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Vascular and endothelial actions of inhibitors of substance P amidation.

R. Caldwell, R. Caldwell, R. B. Caldwell, 2000, Journal of cardiovascular pharmacology.

Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.

Michael L. Gonzales, B. Lucchesi, M. L. Gonzales, 2000, The Journal of pharmacology and experimental therapeutics.

Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model.

B. Lucchesi, S. Rebello, T. Sakurama, 1999, European journal of pharmacology.

Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension

S. Erzurum, S. Comhair, J. Drazba, 2007 .